Chronic and recurrent bone infections occur frequently but have not been explained. Staphylococcus aureus (S. aureus) is often found among chronic and recurrent infections and may be responsible for such infections. One possible reason is that S. aureus can internalize and survive within host cells and by doing so, S. aureus can evade both host defense mechanisms and most conventional antibiotic treatments. In this study, we hypothesized that intra-cellular S. aureus could induce infections in vivo. Osteoblasts were infected with S. aureus and, after eliminating extra-cellular S. aureus, inoculated into an open fracture rat model. Bacterial cultures and radiographic observations at post-operative day 21 confirmed local bone infections in animals inoculated with intra-cellular S. aureus within osteoblasts alone. We present direct in vivo evidence that intra-cellular S. aureus could be sufficient to induce bone infection in animals; we found that intra-cellular S. aureus inoculation of as low as 10 2 colony forming units could induce severe bone infections. Our data may suggest that intra-cellular S. aureus can "hide" in host cells during symptom-free periods and, under certain conditions, they may escape and lead to infection recurrence. Intra-cellular S. aureus therefore could play an important role in the pathogenesis of S. aureus infections, especially those chronic and recurrent infections in which disease episodes may be separated by weeks, months, or even years.
Introduction
Bone infection or osteomyelitis is a significant clinical problem that can lead to prolonged hospitalization, sepsis, poor functional outcome, and even death (Sugarman and Young, 1989; Johnson et al., 2007; de Lissovoy et al., 2009; Pull ter Gunne and Cohen, 2009) . Patients with traumatic open fractures have a high risk of infection (5-33 %) due to microbial contamination and soft tissue damage (Zalavras and Patzakis, 2003) ; such infections are often hard to eradicate, chronic, and recurrent (Berendt and Byren, 2004) . For instance, over a million Americans are hospitalized every year for bone fractures (Canale, 2003) ; such injuries are increasingly common because of increased survivability of high energy trauma in civilian settings as well as in combat activities. Treatment of bone infections, particularly chronic and recurrent infections, frequently requires long-term hospitalization for repeated debridements and prolonged parenteral antibiotic therapy. Bacteria including Staphylococcus aureus (S. aureus), however, are often surprisingly successful in overcoming both host defense mechanisms and antibiotic treatments and result in chronic and recurrent bone infections. Indeed, a high rate of recurrence of bone infections was reported where ~17 % of infections related to traumatic extremity injuries recur (Murray et al., 2008; Murray et al., 2011) . One approach that bacteria may use to elude host defenses and antibiotics is to "hide" themselves intra-cellularly within host cells (Ciampolini and Harding, 2000) .
A wide range of bacterial species related to bone infections has been isolated. The pathogen S. aureus is one of the most common causative agents of bone infections (Sax and Lew, 1999) . S. aureus commonly colonizes the skin, skin glands, and mucous membranes, specifically in the noses of healthy individuals. S. aureus expresses a large number of cell surface proteins (i.e. adhesins) of the microbial surface components that recognize adhesive matrix molecules or MSCRAMMs (Patti and Höök, 1994; Clarke and Foster, 2006) by which it can colonize the bone matrix and adhere to bone cell surfaces. S. aureus, while generally considered an extra-cellular pathogen, is one such bacterium that has the ability to invade and live within different cell types, both phagocytic and nonphagoytic cells (reviewed by Garzoni and Kelley, 2009) . By "hiding" inside the host cells, S. aureus may elude host defenses and most antibiotic treatments, and may be responsible for chronic and recurrent bone infections.
The objective of this study was to determine whether intra-cellular S. aureus can induce bone infections in a rat model. By pre-infecting osteoblasts in vitro with S.
osteoblasts/mL and cultured in 6-well plates overnight in DMEM/F-12 supplemented with 10 % FBS and 1 % penicillin/streptomycin solution to form a monolayer. Fresh S. aureus inoculum was prepared by suspending 5 colonies of S. aureus into 5 mL TSB and incubating at 37 °C for 18 h. The bacterial suspension was centrifuged (3,750 rpm) at 4 °C for 15 min and washed once with PBS; its optical density was adjusted to 5×10 8 colony forming units/mL (CFU/mL) of S. aureus. Rat osteoblasts and S. aureus were then cultured as follows (Fig. 1A) : (i) The osteoblast monolayer was washed twice with PBS. S. aureus was pelleted, re-suspended in DMEM/F-12 (without FBS and antibiotics), and then added to the osteoblast monolayer at a multiplicity of infection (MOI) of 500:1 (S. aureus to osteoblasts). Osteoblasts and S. aureus were next cultured together at 37 °C in a 5 % CO 2 humidified incubator for 2 h. (ii) The osteoblast monolayer was washed twice with PBS to remove any non-adherent bacteria, and cell culture media supplemented with gentamicin (100 μg/mL) was added and kept for 2 h to kill any extra-cellular bacteria. Gentamicin treatment is commonly used to eliminate extra-cellular bacteria (Wright and Friedland, 2002; Jevon, et al., 1999) ; gentamicin is unable to penetrate mammalian cell membranes within short time periods (Plotkowski et al., 1999; Hamad et al., 2010) . After gentamicin treatment, osteoblasts were detached and viable osteoblasts were counted using a hemocytometer (BrightLine Hausser Scientific, Horsham, PA, USA) following the trypan-blue exclusion assay; the viability of osteoblasts was approximately 94.2 ±5.5 %. Infected osteoblasts were immediately used; intra-cellular S. aureus within osteoblasts prior to inoculation into rats was imaged (Fig.  1B) . (iii) Samples of infected osteoblasts were lysed using Triton X-100. (iv) Cell lysates were cultured on blood agar plates to determine the CFU that represented the viable colonies of intra-cellular S. aureus within osteoblasts. To examine the viability of infected osteoblasts at days postinfection, non-infected (control) and infected osteoblasts were cultured in DMEM/F12 supplemented with 5 % FBS 
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and 5 μg/mL lysostaphin solution for 1 and 7 d; media was changed every 3 d for the day 7 samples. Lysostaphin does not penetrate mammalian cell membranes for long time periods, e.g. weeks (Easmon et al., 1978; Kumar, 2008; Maurin and Raoult, 2001 ). The viability of osteoblasts at post-infection days 1 and 7 was calculated relevant to their control (non-infected) cells. The viability of the infected osteoblasts was found to be 84.6 ±6.7 % and 77.4 ±0.6 % at post-infection days 1 and 7, respectively.
Animal groups and open fracture infection procedure
The study was approved by the West Virginia University Institutional Animal Care and Use Committee. Male Sprague-Dawley rats (400-450 g) were obtained from Hilltop Lab Animals (Scottdale, PA). Our open femur fracture rat model (Li et al., 2009; Boyce et al., 2012) was modified and the surgical procedure is described in brief as follows ( Fig. 2 ): After sedation of the animals with intraperitoneal anesthetic, one hind leg was shaved prior to fracture. A midshaft femur fracture was produced using a custom-made device ( Fig. 2A) , the surgical site was disinfected, an incision was made to expose the fracture (Fig. 2B) , and then the fracture was fixed using an intramedullary stainless steel Kirschner wire or K-wire (Fig. 2C) . Next, 100 μL of treatment solution was gently pipetted into the fracture site without contacting the surgical instruments ( Fig. 2D ). Based on the treatment solutions, rats were randomly assigned to one of the following six groups (six rats per group) ( Table 1 ). The incision was carefully closed (Fig. 2E ) and post-operative radiographs were taken to verify fracture fixation. All animals were monitored for the study duration of 3 weeks and euthanized at post-operative day 21. Note that both 10 2 and 10 6 CFU of extra-cellular S. aureus induced bone infections in the same open fracture rat model (Li et al., 2009; Li et al., 2010; Boyce et al., 2012) , and a lower extra-cellular S. aureus dose of 20 CFU, which was expected not to induce infection, was chosen here to evaluate the potential role of intra-cellular S. aureus by comparing Group III with Group VI.
Microbiological and radiographic evaluations
At euthanasia, bone and muscle tissue were collected in 15 mL centrifuge tubes with 5 mL PBS and homogenized. Samples of bone and muscle homogenates were diluted and plated on blood agar plates and S. aureus colonies were counted after incubating the plates at 37 °C for 24 h. In addition, K-wires used to fix the fractured femurs were collected at euthanasia, cut into 2 cm-long pieces, rolled on blood agar plates, and cultured at 37 °C for 24 h. Radiographs were taken at post-operative days 0, 7 and 21.
Body weight and complete blood count
The body weights of the animals were taken on the day of surgery and immediately before euthanasia; the net weight 
Statistical analysis
Values of CFU, body weight gain/loss, and blood cell counts were expressed as mean ± standard deviation. Differences in body weight gain/loss and blood cell counts were analyzed using one-way ANOVA. p value < 0.05 was considered statistically significant. JMP (V9) software was used (SAS Institute, Inc., Cary, NC, USA).
Results
Intra-cellular S. aureus causes high bacterial burden in bone and muscle tissue Rats (Groups IV, V, and VI) inoculated with infected osteoblasts (10 2 or 10 6 CFU of intra-cellular S. aureus) led to high CFU counts (i.e. ~10 6 CFU/mL) at post-operative day 21 in the bone and muscle samples (Fig. 3A ). There were no significant differences in CFU among the groups (i.e. Groups IV, V, and VI) inoculated with infected osteoblasts at post-operative day 21, although relatively higher CFU counts were found in the bone samples compared to the muscle samples of the same group. By contrast, no bacteria were observed at post-operative day 21 in the rats (i.e. Groups I, II, and III) inoculated with PBS, osteoblasts, and osteoblasts combined with 20 CFU of extra-cellular S. aureus (Fig. 3A) . Correspondingly, heavy bacterial growth was seen in the blood agar plates rolled with the K-wires from animals inoculated with infected osteoblasts (10 2 or 10 6 CFU), while no bacterial colonies were found in K-wires extracted from animals inoculated with PBS, osteoblasts, and osteoblasts combined with 20 CFU of extra-cellular S. aureus (Fig. 3B) . Gross observation before euthanasia showed clear pus pockets at the fracture sites in rats inoculated with infected osteoblasts (i.e. Groups IV, V, and VI). No S. aureus growths (data not Group I: PBS; Group II: 10 6 osteoblasts; Group III: 10 6 osteoblasts combined with 20 CFU of extra-cellular S. aureus; Group IV: 10 6 osteoblasts with 10 2 CFU intra-cellular S. aureus; Group V: 10 6 osteoblasts infected with 10 6 CFU intra-cellular S. aureus; Group VI: 10 6 osteoblasts infected with 10 6 CFU intra-cellular S. aureus combined with 20 CFU of extra-cellular S. aureus.
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shown) were observed at post-operative day 21 in any of the blood samples.
Radiographic assessment of bone infection
No signs of infection were observed at post-operative day 21 in the radiographs of rats (i.e. Groups I, II, and III) inoculated with PBS, osteoblasts, and osteoblasts combined with 20 CFU of extra-cellular S. aureus (Fig.  4A) . The radiographic images of these animals were characterized by the formation of normal bridging calluses at the fracture sites. By contrast, groups (i.e. Groups IV, V, and VI) inoculated with infected osteoblasts (10 2 or 10 6 CFU) showed severe osteolysis at post-operative day 21. Meanwhile, no severe osteolysis was observed at postoperative day 7 in the animals inoculated with infected osteoblasts (Fig. 4B) ; this may indicate that it takes time (more than 7 d) to develop infection in this animal model.
Fig. 5.
Net weight loss of the rats at post-operative day 21 was significantly higher in the animal groups inoculated with infected osteoblasts (i.e. Groups V and VI) compared to those in the groups inoculated with PBS, osteoblasts, and a mixture of osteoblasts and 20 CFU of extra-cellular S. aureus (i.e. Groups I, II, and III). Data were an average of six rats in each group. Error bars were standard deviations. Group I: PBS; Group II: 10 6 osteoblasts; Group III: 10 6 osteoblasts combined with 20 CFU of extra-cellular S. aureus; Group IV: 10 6 osteoblasts with 10 2 CFU intracellular S. aureus; Group V: 10 6 osteoblasts infected with 10 6 CFU intra-cellular S. aureus; Group VI: 10 6 osteoblasts infected with 10 6 CFU intra-cellular S. aureus combined with 20 CFU of extra-cellular S. aureus.
Fig. 6.
Complete blood counts at post-operative day 21 showed that neutrophil numbers were significantly higher in the animal groups inoculated with infected osteoblasts (i.e. Groups IV, V, and VI) compared to those groups inoculated with osteoblasts and a mixture of osteoblasts and 20 CFU of extra-cellular S. aureus (i.e. Groups II and III). Error bars were standard deviations. Group I: PBS; Group II: 10 6 osteoblasts; Group III: 10 6 osteoblasts combined with 20 CFU of extra-cellular S. aureus; Group IV: 10 6 osteoblasts with 10 2 CFU intra-cellular S. aureus; Group V: 10 6 osteoblasts infected with 10 6 CFU intra-cellular S. aureus; Group VI: 10 6 osteoblasts infected with 10 6 CFU intra-cellular S. aureus combined with 20 CFU of extra-cellular S. aureus.
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Body weight and complete blood counts A significant loss in body weight was observed in rat groups (i.e. Groups V and VI) inoculated with infected osteoblasts of 10 6 CFU of intra-cellular S. aureus and 10 6 CFU of intracellular S. aureus combined with 20 CFU of extra-cellular S. aureus compared to the groups (i.e. Groups I, II, and III) inoculated with PBS, osteoblasts, and osteoblasts combined with 20 CFU of extra-cellular S. aureus (Fig. 5) . More weight loss was also observed in Group IV inoculated with infected osteoblasts of 10 2 CFU of intra-cellular S. aureus compared to Groups I, II, and III; however, the differences were not statistically significant (Fig. 5) .
The neutrophils in the blood of groups (i.e. Groups IV, V, and VI) inoculated with infected osteoblasts (10 2 or 10 6 CFU) were significantly elevated at post-operative day 21 compared to the groups (i.e. Groups II and III) inoculated with osteoblasts and osteoblasts combined with 20 CFU of extra-cellular S. aureus (Fig. 6) . No significant differences (data not shown) were seen at post-operative day 21 in the numbers of lymphocytes, monocytes, and eosinophils among all the groups studied.
Discussion
S. aureus is a human pathogen causing significant morbidity and mortality in both community-and hospitalacquired infections. Surprisingly, S. aureus frequently overcomes both host defense mechanisms and most antibiotic treatments. It is often found in chronic and recurrent infections and could be responsible for such infections. This bacterium is believed to have developed several means to combat conventional antibiotic therapies, among which are its ability to survive for long periods of time inside host cells (Garzoni and Kelley, 2009) . The purpose of the present study was to examine whether intracellular S. aureus contributes to infection in vivo. Efforts were implemented to completely eradicate extra-cellular S. aureus in the inoculums by treating them with gentamicin; the complete killing of extra-cellular S. aureus was proved in our studies as well as in studies by others (Plotkowski et al., 1999; Hamrick et al., 2003; Hamad et al., 2010; Hamza and Li, 2012) . Also, gentamicin remaining in the inoculums was expected to eliminate any extra-cellular S. aureus that leaked out within the first few hours. We investigated whether intra-cellular S. aureus within osteoblasts could induce infection in our open femur fracture rat model. Note that this model is not an animal model of recurrent infection. This model was chosen because open fractures have high rates of infection and infection recurrence; a high rate of recurrent infections was reported in traumatic extremity injuries (Murray et al., 2008; Murray et al., 2011) . We found that animals inoculated with S. aureus infected osteoblasts with intracellular S. aureus CFU of 10 2 (i.e. Group IV) and 10 6 (i.e. Group V) all led to severe infections, confirmed by culturing bone and muscle tissue from the infection sites and explanted K-wires (Fig. 3 ) and radiographic analysis of the fracture (Fig. 4) . Inoculation of intra-cellular S. aureus alone of 10 2 CFU led to the same degree of infection as 10 6 CFU inoculum, evidenced by approximately the same CFU in bone and muscle tissue at post-operative day 21 (Fig.  3) . Animals inoculated with no bacteria (i.e. Groups I and II) or with 20 CFU of extra-cellular S. aureus (i.e. Group III) did not have evidence of infection at post-operative day 21. No systemic infection was observed in any of the groups investigated because no CFU was found in blood samples. These results suggest that intra-cellular S. aureus inoculum of as low as 10 2 CFU within osteoblasts induced bone infections in our rat open femur fracture model and that the infection was localized.
It was interesting that severe bone infections were induced by intra-cellular S. aureus within osteoblasts at 10 2 CFU, which was the same quantity of inoculum as our previous rat studies where 10 2 CFU of extra-cellular S. aureus was sufficient to induce bone infections in our open fracture rat model (Li et al., 2009; Li et al., 2010; Boyce et al., 2012) . This suggested that not only extracellular but also intra-cellular S. aureus alone at 10 2 CFU could induce severe bone infections in open fractures. Note that inoculation of uninfected osteoblasts did not cause infection; no CFU was observed in corresponding bone, muscle, or K-wire samples (Fig. 3) .
Meanwhile, neutrophils were significantly increased at post-operative day 21 in the groups inoculated with infected osteoblasts. This might suggest that neutrophils have played a deleterious role in infections induced by S. aureus infected osteoblasts. In the literature, neutrophils may have a protective or a deleterious role in S. aureus infection. On the one hand, neutrophils have long been believed to provide significant host defense against S. aureus infection. This is mainly because patients who are neutropenic or who have defects in neutrophil functions are more susceptible to S. aureus infection; total ablation of neutrophils in an experimental mouse model of S. aureus-induced septic arthritis led to decreased survival of the animals and increased bacteremia (Verdrengh and Tarkowski, 1997) . On the other hand, increased neutrophils were also found to correlate with decreased survival of mice and increased bacterial burden at the infection site (Lowrance et al., 1994; Caver et al., 1996) .
It is important to note that both in vitro and in vivo studies have shown that bacteria like S. aureus and S. epidermidis can internalize and survive within both phagocytic and non-phagocytic cells. In vitro, S. aureus can invade and survive within polymorphonuclear neutrophils and monocytes (Rogers and Tompsett, 1952; Kapral and Shayegani, 1959; Melly et al., 1960) , endothelial cells (Vriesema et al., 2000) , and osteoblasts Jevon et al., 1999; Ellington et al., 2003) . Infected human osteoblasts were shown to release viable S. aureus, which was able to re-infect new osteoblasts (Ellington et al., 2003) , while in this study the viability of infected osteoblasts decreased slightly over time (84.6 ±6.7 % at post-infection day 1 vs. 77.4 ±0.6 % at day 7). S. aureus can also internalize and perhaps even replicate within bovine mammary epithelial cells, both in cell lines and in primary culture (Almeida et al., 1996; Bayles et al., 1998) . In vivo, intra-cellular S. aureus and S. epidermidis were found, in a few limited cases, in animals and patients.
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In animal studies, S. epidermidis was found to persist in macrophages in mice and may play an important role in the pathogenesis of biomaterial-associated infection (Boelens et al., 2000; Broekhuizen et al., 2008) . S. aureus was found to be able to internalize and survive in osteoblasts of chick embryos (Reilly et al., 2000) and in bovine alveolar cells isolated from milk of infected cows (Hébert et al., 2000) . More interestingly, S. aureus (~1×10 6 CFU) surviving in neutrophils was able to establish infection after being injected intraperitoneally into naïve mice (Gresham et al., 2000) . In human studies, intra-cellular S. aureus was found inside epithelium, glandular and myofibroblastic cells in intranasal biopsy specimens obtained, during infection symptom-free periods, from three patients with recurrent rhinosinusitis (Clement et al., 2005) . Molecular typing proved the clonal relationship of the patientspecific Staphylococci. Intra-cellular S. aureus was also found in surgical bone specimens from a patient who had chronic, recurrent bone infection (Bosse et al., 2005) . The intra-cellular S. aureus appeared to be sequestered and protected from the host immune system within the osteoblast or osteocyte cytoplasm for years (Bosse et al., 2005) . In another case, intra-cellular S. aureus was cultured from five patients with persistent recurring osteomyelitis infections (Proctor et al., 1995) . Alarmingly, some of the intra-cellular S. aureus were small-colony variants which were nonhemolytic and nonpigmented, grew very slowly on routine culture media, and were resistant to aminoglycosides under routine conditions. Therefore, there is some in vitro and in vivo evidence supporting the potential role of intra-cellular S. aureus in Staphylococci pathogenesis. The results presented here are important because they demonstrate that intra-cellular S. aureus can induce infection in vivo. Bacteria (e.g. S. aureus) could internalize and survive within host cells (e.g. osteoblasts) and, after "hiding" for some time period (could be up to years, see Bosse et al., 2005) , these quiescent bacteria could escape from the infected host cells into the surrounding tissue and could be sufficient to initiate a recurrence of symptomatic infection. It is also possible that, upon escaping from the host cells, bacteria may internalize into other host cells (e.g. neutrophils, macrophages). All of these may help to understand the pathogenesis of infections like periprosthetic joint infection, with which high infection recurrence (8-11 %) has been reported (Lieberman et al., 1994; Takahira et al., 2003) even after extensive antibiotic treatments during the two-stage exchange arthroplasty (gold standard in North America).
Taken together, our findings present direct in vivo evidence that intra-cellular S. aureus could induce bone infections and could be responsible for chronic and recurrent infections. These findings also suggested that as low as 10 2 CFU of intra-cellular S. aureus could induce severe bone infections in open fractures. These findings may greatly advance our understanding of the pathogenesis of bone infections, especially for chronic and recurrent infections. The induction of bone infections by intracellular S. aureus was studied in this work; however, the findings are expected to be applicable to other infections/ diseases and intra-cellular pathogens.
